Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Debt Ratio (2016 - 2017)

Historic Debt Ratio for Corcept Therapeutics (CORT) over the last 2 years, with Q2 2017 value amounting to 0.05.

  • Corcept Therapeutics' Debt Ratio fell 8653.17% to 0.05 in Q2 2017 from the same period last year, while for Jun 2017 it was 0.05, marking a year-over-year decrease of 8653.17%. This contributed to the annual value of 0.21 for FY2016, which is N/A changed from last year.
  • Per Corcept Therapeutics' latest filing, its Debt Ratio stood at 0.05 for Q2 2017, which was down 8653.17% from 0.13 recorded in Q1 2017.
  • In the past 5 years, Corcept Therapeutics' Debt Ratio ranged from a high of 0.47 in Q1 2016 and a low of 0.05 during Q2 2017